🇺🇸 FDA
Patent

US 9630931

Pharmaceutically active pyrazine derivatives

granted A61KA61K31/497A61K31/5377

Quick answer

US patent 9630931 (Pharmaceutically active pyrazine derivatives) held by SENTINEL ONCOLOGY LIMITED expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTINEL ONCOLOGY LIMITED
Grant date
Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/497, A61K31/5377, A61K45/06, A61P